Rhythm Pharmaceuticals Statistics

Total Valuation

BMV:RYTM has a market cap or net worth of MXN 127.01 billion. The enterprise value is 124.17 billion.

Market Cap	127.01B
Enterprise Value	124.17B

Important Dates

The next estimated earnings date is Tuesday, February 24, 2026.

Earnings Date	Feb 24, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	66.74M
Shares Outstanding	n/a
Shares Change (YoY)	+5.39%
Shares Change (QoQ)	+4.05%
Owned by Insiders (%)	0.67%
Owned by Institutions (%)	90.44%
Float	55.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.72
PB Ratio	23.42
P/TBV Ratio	48.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-34.24
EV / Sales	39.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.75, with a Debt / Equity ratio of 0.38.

Current Ratio	4.75
Quick Ratio	4.31
Debt / Equity	0.38
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.70

Financial Efficiency

Return on equity (ROE) is -85.79% and return on invested capital (ROIC) is -34.50%.

Return on Equity (ROE)	-85.79%
Return on Assets (ROA)	-26.74%
Return on Invested Capital (ROIC)	-34.50%
Return on Capital Employed (ROCE)	-46.25%
Revenue Per Employee	11.30M
Profits Per Employee	-12.81M
Employee Count	283
Asset Turnover	0.40
Inventory Turnover	1.03

Taxes

In the past 12 months, BMV:RYTM has paid 8.03 million in taxes.

Income Tax	8.03M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +94.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+94.86%
50-Day Moving Average	577.77
200-Day Moving Average	n/a
Relative Strength Index (RSI)	78.94
Average Volume (20 Days)	3,380

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	8.33

Income Statement

In the last 12 months, BMV:RYTM had revenue of MXN 3.20 billion and -3.63 billion in losses. Loss per share was -56.97.

Revenue	3.20B
Gross Profit	2.86B
Operating Income	-3.42B
Pretax Income	-3.52B
Net Income	-3.63B
EBITDA	-3.39B
EBIT	-3.42B
Loss Per Share	-56.97

Full Income Statement

Balance Sheet

The company has 7.63 billion in cash and 2.07 billion in debt, giving a net cash position of 5.56 billion.

Cash & Cash Equivalents	7.63B
Total Debt	2.07B
Net Cash	5.56B
Net Cash Per Share	n/a
Equity (Book Value)	5.42B
Book Value Per Share	40.93
Working Capital	7.16B

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.00B
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 89.40%, with operating and profit margins of -106.81% and -110.32%.

Gross Margin	89.40%
Operating Margin	-106.81%
Pretax Margin	-110.07%
Profit Margin	-110.32%
EBITDA Margin	-105.98%
EBIT Margin	-106.81%
FCF Margin	n/a

Dividends & Yields

BMV:RYTM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.39%
Shareholder Yield	-5.39%
Earnings Yield	-2.86%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:RYTM has an Altman Z-Score of 8.47 and a Piotroski F-Score of 5.

Altman Z-Score	8.47
Piotroski F-Score	5